Get the Stockscreener App
2.42
6.92%
-0.18
After Hours:
2.50
0.08
+3.31%
Accendra Health Inc stock is traded at $2.42, with a volume of 647.09K.
It is down -6.92% in the last 24 hours and up +19.21% over the past month.
Accendra Health Inc is a nationwide provider of products, technology, and services that support health beyond the hospital by connecting patients, providers, and insurers. Through its brands, Apria and Byram Healthcare, the company delivers disposable medical supplies, integrated home healthcare equipment, and related services that help improve health outcomes and quality of life for individuals with chronic, complex, and acute health conditions. Its offerings span diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment, along with patient support services. The company also supplies a broad range of home medical equipment and patient care products, including ostomy, wound care, urology, and incontinence solutions.
See More
Previous Close:
$2.60
Open:
$2.63
24h Volume:
647.09K
Relative Volume:
1.30
Market Cap:
$187.18M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
2.1786
EPS:
1.1108
Net Cash Flow:
-
1W Performance:
-2.42%
1M Performance:
+19.21%
6M Performance:
-82.02%
1Y Performance:
-82.02%
1-Day Range:
$2.34
$2.63
1-Week Range:
$2.0223
$2.71
52-Week Range:
$1.885
$2.71
Accendra Health Inc Stock (ACH) Company Profile
Name
Accendra Health Inc
Sector
Industry
Phone
(804) 277-4304
Address
10900 NUCKOLS ROAD, GLEN ALLEN
Compare ACH vs MCK, COR, CAH, HSIC, AHG
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ACH
Accendra Health Inc
|
2.42 | 201.10M | 0 | 0 | 0 | 0.00 |
|
MCK
Mckesson Corporation
|
974.45 | 117.98B | 397.96B | 4.55B | 9.64B | 34.77 |
|
COR
Cencora Inc
|
366.65 | 70.62B | 325.78B | 1.64B | 3.61B | 8.3139 |
|
CAH
Cardinal Health Inc
|
227.13 | 53.22B | 244.67B | 1.68B | 5.51B | 6.9487 |
|
HSIC
Henry Schein Inc
|
81.47 | 9.64B | 12.50B | 314.00M | 421.00M | 2.44 |
|
AHG
Akso Health Group Adr
|
1.40 | 1.10B | 2.22M | -5.63M | -1.68M | -0.24 |
Accendra Health Inc Stock (ACH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-03-25 | Downgrade | UBS | Buy → Neutral |
| Jul-19-24 | Upgrade | Citigroup | Neutral → Buy |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Jan-03-24 | Initiated | Barclays | Equal Weight |
| Oct-13-22 | Downgrade | Citigroup | Buy → Neutral |
| Oct-12-22 | Downgrade | BofA Securities | Buy → Underperform |
| Oct-12-22 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Apr-26-22 | Resumed | Citigroup | Buy |
| Apr-01-22 | Resumed | Credit Suisse | Neutral |
| Mar-30-22 | Resumed | JP Morgan | Underweight |
| Mar-23-22 | Upgrade | HSBC Securities | Reduce → Hold |
| Apr-08-21 | Upgrade | JP Morgan | Neutral → Overweight |
| Mar-08-21 | Upgrade | Goldman | Sell → Buy |
| Dec-17-20 | Upgrade | UBS | Neutral → Buy |
| Sep-25-20 | Upgrade | Barclays | Underweight → Equal Weight |
| Jul-21-20 | Upgrade | BofA Securities | Neutral → Buy |
| Jul-21-20 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Jul-14-20 | Upgrade | Credit Suisse | Neutral → Outperform |
| May-05-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Apr-23-20 | Resumed | Credit Suisse | Neutral |
| Jan-21-20 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Jan-07-20 | Downgrade | Goldman | Neutral → Sell |
| Nov-15-19 | Upgrade | CLSA | Underperform → Outperform |
| Sep-06-19 | Reiterated | BofA/Merrill | Neutral |
| Apr-10-19 | Reiterated | BofA/Merrill | Neutral |
| Apr-03-19 | Upgrade | BofA/Merrill | Neutral → Buy |
| Apr-01-19 | Upgrade | JP Morgan | Underweight → Overweight |
| Jan-18-19 | Upgrade | HSBC Securities | Hold → Buy |
| Jan-17-19 | Initiated | UBS | Neutral |
| Jan-15-19 | Upgrade | CLSA | Underperform → Outperform |
| Dec-14-18 | Downgrade | Morgan Stanley | Overweight → Underweight |
| Dec-12-18 | Downgrade | Goldman | Buy → Neutral |
| Sep-28-18 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Apr-11-18 | Downgrade | CLSA | Outperform → Sell |
| Apr-10-18 | Upgrade | Credit Suisse | Neutral → Outperform |
| Mar-26-18 | Upgrade | Goldman | Sell → Neutral |
| Nov-02-17 | Downgrade | HSBC Securities | Buy → Hold |
| Mar-24-16 | Upgrade | Goldman | Sell → Neutral |
| Dec-07-15 | Downgrade | Goldman | Neutral → Sell |
| Aug-31-15 | Upgrade | Credit Suisse | Underperform → Neutral |
| Aug-01-12 | Initiated | HSBC Securities | Underweight |
| Aug-05-09 | Upgrade | Citigroup | Sell → Buy |
| Dec-01-08 | Downgrade | HSBC Securities | Neutral → Underweight |
View All
Accendra Health Inc Stock (ACH) Latest News
Owens & Minor, Inc. (NYSE:OMI) Q4 2025 Earnings Call Transcript - Insider Monkey
Accendra Health (ACH) Price Target Decreased by 12.16% to 3.32 - Nasdaq
Accendra Health (ACH) Reports 2025 Revenue of $2.8B and Shift Toward Core Home-Based Care - Insider Monkey
UBS cuts Accendra Health stock price target on 2026 guidance By Investing.com - Investing.com Canada
UBS cuts Accendra Health stock price target on 2026 guidance - Investing.com South Africa
Tighter CMS Coverage Rules Put Accendra Health’s Non-Invasive Ventilation Revenue and Liquidity at Risk - TipRanks
Accendra Health: Debt Reduction Creates Long-Term Opportunity (Upgrade) (NYSE:ACH) - Seeking Alpha
Accendra Health (ACH) Faces Lowered Price Target by Leerink Part - GuruFocus
Accendra Health bets on Optum contract, leaner structure - HME News
Accendra Health : Reports Fourth Quarter 2025 Financial Results Prepared Remarks - marketscreener.com
Accendra Health sees 3% YOY growth, embarks on ‘next chapter’ - HME News
Accendra Health earnings missed by $0.01, revenue fell short of estimates - Investing.com Nigeria
Accendra Health Inc (ACH) Q4 2025 Earnings Call Highlights: Navi - GuruFocus
Accendra Health reports Q4 adjusted EPS 21c, consensus 22c - TipRanks
Accendra Health Posts 2025 Results, Guides 2026 Outlook - TipRanks
Accendra Health Reports Fourth Quarter 2025 Financial Results - marketscreener.com
Earnings Scheduled For February 19, 2026 - Benzinga
Accendra Health Announces Fourth Quarter 2025 Earnings Release Date and Conference Call - Business Wire
MSN Money - MSN
Accendra Health Stock Surges on Key Executive Appointment - AD HOC NEWS
Owens & Minor Appoints Dirk Benson as Chief Commercial Officer, Effective February 4, 2026 - marketscreener.com
Accendra Health Begins Trading Under 'ACH' Ticker After Owens & Minor Divestment - marketscreener.com
Owens & Minor, Inc. (OMI) Stock Analysis: Exploring a 94% Potential Upside in Healthcare Distribution - DirectorsTalk Interviews
Owens & Minor changes name to Accendra Health - MSN
Owens & Minor, Inc. (OMI): Investor Outlook Reveals 94% Potential Upside Amidst Challenging Valuation - DirectorsTalk Interviews
AASTOCKS Financial NewsAccendra Health, Inc. (ACH) - AASTOCKS.com
Owens & Minor rebrands as Accendra Health in transformation - MSN
Accendra Health (ACH) Price Target Decreased by 69.55% to 3.77 - Nasdaq
Accendra Health (ACH): Citigroup Lowers Price Target, Maintains Buy Rating | ACH Stock News - GuruFocus
Implied Volatility Surging for Accendra Health Stock Options - sharewise.com
ACH (Accendra Health) Interest Coverage : 1.94 (As of Sep. 2025) - GuruFocus
ACH (Accendra Health) Current Deferred Revenue : $0 Mil (As of Sep. 2025) - GuruFocus
ACH (Accendra Health) ROCE % : 6.66% (As of Sep. 2025) - GuruFocus
Return on assets % of Accendra Health, Inc. – NYSE:ACH - TradingView — Track All Markets
Accendra Health, Inc. Revenue Breakdown – NYSE:ACH - TradingView — Track All Markets
Total debt per share of Accendra Health, Inc. – NYSE:ACH - TradingView — Track All Markets
ETFs Investing in Accendra Health, Inc. Stocks - TradingView — Track All Markets
ACH Forecast — Price Target — Prediction for 2027 - TradingView
Gree Says Won’t Hike Air-Con Prices, Swap Copper for Aluminum Despite Metal’s Surging Cost - Yicai Global
Accendra Health, Inc. Bonds — Corporate Bond Rates - TradingView — Track All Markets
Total revenue of Accendra Health, Inc. – BOATS:ACH - TradingView — Track All Markets
Accendra Health (NYSE: OMI) adds pro forma data on P&HS sale - Stock Titan
China Metals & Mining Industry Report 2025, Profiles of Jiangxi Copper, China Shenhua Energy Co, Zijin Mining Group, Aluminum Corp of China - Yahoo Finance
It’s official: Accendra Health goes live on NYSE, unveils new website - HME News
"Post-70s" Lu Dongliang became Vice Governor of Shanxi Province before becoming Chairman of Aluminum Corporation of China - Shanghai Metals Market
Owens & Minor Completes Sale of Products & Healthcare Services Business to Platinum Equity - citybiz
ACH Seasonals Chart - TradingView — Track All Markets
Revenue per share of Accendra Health Inc – SWB:6OM - TradingView — Track All Markets
Accendra Health, Inc. Financial Disclosures & SEC Filings - TradingView — Track All Markets
Free cash flow per share of Accendra Health Inc – SWB:6OM - TradingView — Track All Markets
Chalco’s Stock Tests Investor Nerves As Aluminum Cycle Turns: Is The Worst Finally Priced In? - AD HOC NEWS
Accendra Health Inc Stock (ACH) Financials Data
There is no financial data for Accendra Health Inc (ACH). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
3.59%
0.56%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):